The JD.com, Shanghai Pharma and SoftBank China Venture Capital-backed O2O medical services operator, has secured fresh funding from investors including Sinocare.
China-based digital hospital and drugstore operator Shanghai Pharma Health (SPH) Commerce completed an RMB1.03bn ($160m) series B round last month featuring diabetes management technology provider Sinocare, Sina Finance has reported. JIC Investment, a vehicle for investment firm China Jianyin Investment, co-led the round with local government-backed Shanghai Biomedical Industrial Equity Investment Fund. It included Ample…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
